| Literature DB >> 33330406 |
Yan Shi1, Liying Zhou1,2, Le Li1,2, Mengxi Liu1, Huosheng Qiang1, Min Shen1, Baohua Shen1, Hang Chen1, Olaf H Drummer3, Wanhui Liu2, Hejian Wu1, Ping Xiang1.
Abstract
Methyl 2 -[ [ 1- (5- fluoropentyl) indole - 3- carbonyl] amino] -3, 3- dimethyl - butanoate (5F-MDMB-PICA) is a new synthetic cannabinoid characterized by valinate or tert-leucinate moieties. In recent years, 5F-MDMB-PICA has been abused in the form of "spice-like" herbal incenses or electronic cigarette oil. A UHPLC-MS/MS method was developed to detect 5F-MDMB-PICA and its metabolites in human hair. Approximately 20 mg of hair was weighed and pulverized with methanol below 4°C. After ultrasonication, centrifugation and filtration, 200 μL of supernatant was placed into an autosampler vial and analyzed on a Waters Acquity UPLC HSS T3 column (100 mm × 2.1 mm, 1.8 μm particle size) using an acetonitrile-20 mmol/L ammonium acetate (0.1% formic acid, 5% acetonitrile) gradient with a run time of 8 min. The limit of detection (LOD) ranged from 0.5 to 5 pg/mg, and the lower limit of quantitation (LLOQ) ranged from 1 to 5 pg/mg. The method was shown to be linear over a concentration range of 1-200 pg/mg. The linear correlation (R 2) of the calibration curves for all analytes was >0.999. The accuracy varied from 95.4 to 107.4%, while the intra- and inter-day precision RSD values were 0.7-10.6% and 1.7-12.2%, respectively. Recoveries were within the range of 61.1-93.3%, and matrix effects were in the range of 19.1-102.6%. The validated method was successfully applied to the identification and quantification of 5F-MDMB-PICA and its metabolites in hair from authentic forensic cases.Entities:
Keywords: 5F-MDMB-PICA; UHPLC-MS/MS; hair analysis; metabolites; synthetic cannabinoid
Year: 2020 PMID: 33330406 PMCID: PMC7732586 DOI: 10.3389/fchem.2020.610312
Source DB: PubMed Journal: Front Chem ISSN: 2296-2646 Impact factor: 5.221
Scheme 1Chemical structures of 5F-MDMB-PICA and its metabolites used for method validation.
MRM parameters and retention times for 5F-MDMB-PICA, its metabolites and the IS.
| 5F-MDMB-PICA | C21H29FN2O3 | 377.2 | 232.2 | 50 | 25 | 3.35 |
| 144.0 | 50 | 55 | 3.35 | |||
| M2 | C21H29FN2O3 | 375.3 | 230.0 | 75 | 22 | 2.89 |
| 144.0 | 75 | 48 | 2.89 | |||
| M4 | C20H27FN2O4 | 379.1 | 248.2 | 60 | 18 | 2.44 |
| 143.9 | 60 | 44 | 2.44 | |||
| M7 | C20H27FN2O3 | 363.1 | 232.0 | 55 | 23 | 2.85 |
| 144.0 | 55 | 51 | 2.85 | |||
| M8 | C19H24N2O5 | 361.1 | 216.0 | 40 | 20 | 2.69 |
| 144.0 | 40 | 55 | 2.68 | |||
| M9 | C21H29FN2O3 | 393.1 | 248.1 | 60 | 21 | 2.88 |
| 240.1 | 60 | 32 | 2.88 | |||
| JWH-014 Hydroxypentyl metabolite-D5 | C24H18D5NO2 | 363.3 | 155.0 | 80 | 28 | 3.12 |
| 127.0 | 80 | 60 | 3.12 |
quantifier ions; DP, declustering potential; CE, collision potential; Rt, retention time.
Scheme 2Chromatograms of 5F-MDMB-PICA and its metabolites extracted from human hair at the LLOQ (I pg/mg for 5F-MDMB-PICA, M2, M9; 2 pg/mg for M4, M7; and 5 pg/mg for M8).
Linearity, LOD, and LLOQ for 5F-MDMB-PICA and its metabolites in hair.
| 5F-MDMB-PICA | 1–200 | y = 0.07073x + 0.01786 | 0.9992 | 0.5 | 1 |
| M2 | 1–200 | y = 0.08282x + 0.01135 | 0.9991 | 0.5 | 1 |
| M4 | 2–200 | y = 0.03617x – 0.00555 | 0.9994 | 1 | 2 |
| M7 | 2–100 | y = 0.04442x – 0.03089 | 0.9992 | 1 | 2 |
| M8 | 5–200 | y = 0.03365x – 0.00790 | 0.9992 | 5 | 5 |
| M9 | 1–200 | y = 0.08553x – 0.02541 | 0.9989 | 0.5 | 1 |
Intra-day and inter-day accuracy and precision, matrix effect and recovery for 5F-MDMB-PICA and its metabolites in hair.
| 5F-MDMB-PICA | 1 | 6.6 | 105.0 | 5.8 | 98.8 | 23.0 | 1.2 | 72.5 |
| 10 | 1.2 | 102.6 | 2.5 | 100.9 | 19.7 | 0.8 | 78.1 | |
| 50 | 4.0 | 99.8 | 4.9 | 101.3 | 19.1 | 1.7 | 91.8 | |
| 150 | 2.8 | 99.4 | 5.6 | 96.8 | 20.2 | 1.1 | 93.3 | |
| M2 | 1 | 1.2 | 97.4 | 8.3 | 95.0 | 53.5 | 4.9 | 83.8 |
| 10 | 4.3 | 104.2 | 6.5 | 101.3 | 43.0 | 2.5 | 80.8 | |
| 50 | 4.5 | 99.0 | 7.4 | 101.0 | 40.6 | 4.1 | 81.5 | |
| 150 | 6.1 | 100.1 | 10.0 | 95.4 | 41.0 | 2.8 | 77.2 | |
| M4 | 2 | 1.2 | 101.2 | 5.0 | 102.3 | 90.4 | 11.4 | 64.4 |
| 10 | 4.2 | 103.7 | 4.2 | 97.6 | 102.6 | 6.9 | 60.7 | |
| 50 | 4.1 | 98.0 | 4.5 | 99.6 | 98.3 | 6.6 | 76.0 | |
| 150 | 2.4 | 99.9 | 7.3 | 98.7 | 93.9 | 7.7 | 81.5 | |
| M7 | 2 | 0.7 | 104.2 | 7.8 | 105.7 | 55.6 | 4.3 | 63.3 |
| 10 | 1.6 | 100.4 | 6.0 | 97.0 | 59.7 | 6.1 | 61.1 | |
| 50 | 1.8 | 96.1 | 4.6 | 99.8 | 59.2 | 7.2 | 77.5 | |
| 150 | 6.0 | 101.3 | 8.5 | 98.3 | 58.9 | 2.5 | 83.3 | |
| M8 | 5 | 2.8 | 97.7 | 5.3 | 101.3 | 30.2 | 2.2 | 63.0 |
| 20 | 1.2 | 101.8 | 1.7 | 99.5 | 33.6 | 2.0 | 76.1 | |
| 50 | 1.3 | 97.6 | 4.1 | 98.3 | 35.6 | 4.2 | 79.4 | |
| 150 | 5.0 | 100.5 | 7.7 | 100.1 | 36.8 | 2.0 | 85.6 | |
| M9 | 1 | 10.8 | 107.4 | 12.2 | 101.0 | 57.2 | 8.3 | 70.6 |
| 10 | 1.1 | 98.8 | 6.5 | 101.2 | 46.2 | 3.6 | 71.6 | |
| 50 | 1.5 | 95.4 | 6.9 | 98.6 | 46.0 | 2.6 | 70.8 | |
| 150 | 2.4 | 101.7 | 11.5 | 94.7 | 48.4 | 4.0 | 72.2 | |
Stability of 5F-MDMB-PICA and its metabolites in human hair.
| 5F-MDMB-PICA | 1 | 100.6 | 100.8 | 105.0 |
| 10 | 100.2 | 99.2 | 100.8 | |
| 50 | 99.7 | 100.4 | 99.1 | |
| 150 | 100.0 | 99.8 | 101.0 | |
| M2 | 1 | 102.2 | 103.4 | 103.7 |
| 10 | 98.9 | 101.0 | 100.5 | |
| 50 | 97.4 | 98.2 | 99.7 | |
| 150 | 101.2 | 100.6 | 100.5 | |
| M4 | 2 | 103.7 | 101.8 | 96.8 |
| 10 | 99.2 | 100.0 | 100.9 | |
| 50 | 94.7 | 96.7 | 99.6 | |
| 150 | 101.8 | 101.0 | 99.1 | |
| M7 | 2 | 101.7 | 104.4 | 105.3 |
| 10 | 99.4 | 98.7 | 101.6 | |
| 50 | 99.7 | 96.8 | 99.8 | |
| 150 | 100.2 | 100.8 | 100.6 | |
| M8 | 5 | 100.6 | 103.4 | 102.5 |
| 20 | 100.4 | 100.8 | 104.4 | |
| 50 | 98.7 | 95.0 | 94.3 | |
| 150 | 100.4 | 101.0 | 101.4 | |
| M9 | 1 | 97.1 | 105.8 | 102.2 |
| 10 | 103.9 | 100.3 | 100.2 | |
| 50 | 100.2 | 98.0 | 97.0 | |
| 150 | 99.6 | 100.9 | 101.3 | |
Case Information and toxicology results.
| 1 | 22 | Female | 1–3 | 77 | nd | nd | <2 | nd | nd |
| 4–6 | 283 | <1 | nd | <2 | nd | nd | |||
| 2 | 53 | Male | 1–3 | 46 | nd | <2 | 2.7 | <5 | <1 |
| 4–6 | 349 | <1 | <2 | <2 | <5 | <1 | |||
| 3 | 25 | Male | 1–3 | 275 | <1 | nd | 2.8 | <5 | nd |
| 4–6 | 1025 | 3.0 | <2 | 5.6 | <5 | <1 | |||
| 4 | 36 | Male | 1–3 | 2 | nd | <2 | <2 | <5 | <1 |
| 4–6 | nd | nd | nd | nd | nd | nd | |||
detected below the LLOQ; nd, not detected.
Scheme 3Ion chromatograms of case 3.